IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Sep 10, 2021 · 10-Q · 72 days after period end · 0000950170-21-001767
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Net Income | -$3.05M | -$2.87M |
| EPS Diluted | -$1.00 | -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Sep 10, 2021 · 72 d after period end
